We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Novel Mass Spectroscopy-Based Analysis System May Revolutionize Proteomics Research

By LabMedica International staff writers
Posted on 26 Apr 2012
Print article
Image: The TripleTOF 5600 System (Photo courtesy of AB Sciex).
Image: The TripleTOF 5600 System (Photo courtesy of AB Sciex).
An American-Swiss collaborative effort has resulted in a new mass spectrometry-based proteomics research method that can quantify nearly all peptides and proteins in a sample from a single analysis.

A team comprised of investigators from the Swiss Federal Institute of Technology (ETH Zurich; Switzerland) and their colleagues from the American company AB SCIEX (Framingham, MA, USA) have completed development of the groundbreaking mass spectrometry system, MS/MSALL with SWATH Acquisition.

This system, which is fully described in the January 18, 2012, online edition of the journal Molecular and Cellular Proteomics, uses a data-independent MS/MS acquisition method to systematically generate complete, high-specificity fragment ion maps that can be queried for the presence and quantity of any protein of interest using a targeted data analysis strategy. The new method depends on AB SCIEX’s advanced hybrid quadrupole-time of flight mass spectrometer, the TripleTOF 5600 System.

“SWATH Acquisition allows us to explore multiplexed MS/MS datasets to a level that was not possible with traditional clustering or database approaches,” said senior author Dr. Ruedi Aebersold, professor of molecular biology at ETH Zurich. “By collaborating with AB SCIEX to develop the technique on the TripleTOF 5600, we have made this breakthrough method available for proteomics researchers to conduct comprehensive quantitation on the entire proteome.”

Related Links:

ETH Zurich
AB SCIEX


Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
Automated Blood Typing System
IH-500 NEXT
New
Urine Bone Markers Control
Lyphochek Urine Bone Markers Control
New
Automated Nucleic Acid Extractor
eLab

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.